{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:21:00Z","timestamp":1779373260974,"version":"3.53.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1993,3,1]],"date-time":"1993-03-01T00:00:00Z","timestamp":730944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1993,3,1]],"date-time":"1993-03-01T00:00:00Z","timestamp":730944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1993,3]]},"DOI":"10.1016\/0002-9343(93)90056-u","type":"journal-article","created":{"date-parts":[[2004,5,25]],"date-time":"2004-05-25T08:02:11Z","timestamp":1085472131000},"page":"251-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["\u03b2-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: Risk factors and implications for dosing in patients with liver disease"],"prefix":"10.1016","volume":"94","author":[{"given":"Nina","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Mieles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn M.","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/0002-9343(93)90056-U_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(80)90386-1","article-title":"Piperacillin therapy for serious bacterial infections","volume":"69","author":"Winston","year":"1980","journal-title":"Am J Med"},{"issue":"Suppl A","key":"10.1016\/0002-9343(93)90056-U_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/9.suppl_A.273","article-title":"The safety and tolerance of mezlocillin","volume":"9","author":"Parry","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/0002-9343(93)90056-U_bib3","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1093\/clinids\/4.Supplement_2.S481","article-title":"Cefotaxime and cephalosporins: adverse reactions in perspective","volume":"4","author":"Smith","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/0002-9343(93)90056-U_bib4","doi-asserted-by":"crossref","first-page":"S472","DOI":"10.1093\/clinids\/4.Supplement_2.S472","article-title":"Cefotaxime therapy for patients with osteomyeliltis and septic arthritis","volume":"4","author":"Mader","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/0002-9343(93)90056-U_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/infdis\/152.1.90","article-title":"Inhibition of granulopoiesis in vim and vitro by beta-lactam antibiotics","volume":"152","author":"Neftel","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/0002-9343(93)90056-U_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00007611-198006000-00019","article-title":"Neutropenia induced by semisynthetic penicillin","volume":"73","author":"Carpenter","year":"1980","journal-title":"South Med J"},{"key":"10.1016\/0002-9343(93)90056-U_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jac\/25.3.449","article-title":"A prospective study of neutropenia induced by high doses of beta-lactam antibiotics","volume":"25","author":"Olaison","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/0002-9343(93)90056-U_bib8","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Bradford Hill","year":"1965"},{"key":"10.1016\/0002-9343(93)90056-U_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.1974.03240010045029","article-title":"Adverse reactions to antimicrobial agents","volume":"230","author":"Caldwell","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/0002-9343(93)90056-U_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0022-3476(78)81251-7","article-title":"Clinical and pharmacokinetic evaluation of nafcillin in infants and children","volume":"93","author":"Feldman","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/0002-9343(93)90056-U_bib11","series-title":"Principles and practice of infectious diseases","first-page":"230","article-title":"Penicillins","author":"Neu","year":"1990"},{"key":"10.1016\/0002-9343(93)90056-U_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archinte.1978.03630310009008","article-title":"Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureus infections","volume":"138","author":"Kancir","year":"1978","journal-title":"Arch Intern Med"},{"key":"10.1016\/0002-9343(93)90056-U_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1542\/peds.58.3.329","article-title":"A ten year assessment of methicllin-associated side-effects","volume":"58","author":"Yow","year":"1976","journal-title":"Pediatrics"},{"key":"10.1016\/0002-9343(93)90056-U_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/clinids\/13.1.68","article-title":"Adverse reactions to prolonged treatment with high doses of carbenicillin and ureidopenicillins","volume":"12","author":"Lang","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/0002-9343(93)90056-U_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/27.1.95","article-title":"The effect of amphotericin B, aztreonam, imipenem and cephalosporins on the bone marrow progenitor cell activity","volume":"27","author":"Charak","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/0002-9343(93)90056-U_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/6.suppl_A.69","article-title":"Metabolism of cefotaxime in animals and man","volume":"6","author":"Chamberlain","year":"1980","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl A","key":"10.1016\/0002-9343(93)90056-U_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/6.suppl_A.93","article-title":"Humann metabolism of cefotaxime","volume":"6","author":"Reeves","year":"1980","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/0002-9343(93)90056-U_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/cpt1975184475","article-title":"Pharmacokinetics of ampicillin in cirrhosis","volume":"18","author":"Lewis","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/0002-9343(93)90056-U_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000238238","article-title":"Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of liver","volume":"30","author":"Hoffken","year":"1984","journal-title":"Chemotherapy"},{"key":"10.1016\/0002-9343(93)90056-U_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/AAC.31.2.323","article-title":"Imapired clearance of ceftizoxime and cefotaxime after orthotopic liver transplantation","volume":"31","author":"Burckart","year":"1971","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0002-9343(93)90056-U_bib21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/j.1552-4604.1991.tb03767.x","article-title":"Pharmacokinetics of ceftriaxone in liver transplant recipients","volume":"31","author":"Toth","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/0002-9343(93)90056-U_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF01647000","article-title":"Pharmacokinetics of cefotaxime in patients after liver transplantation","volume":"5","author":"Kuse","year":"1990","journal-title":"Infection"},{"key":"10.1016\/0002-9343(93)90056-U_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003495-197917030-00005","article-title":"Drug prescribing in hepatobilary disease","volume":"17","author":"Roberts","year":"1979","journal-title":"Drugs"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000293439390056U?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000293439390056U?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:03:01Z","timestamp":1756882981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/000293439390056U"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,3]]}},"alternative-id":["000293439390056U"],"URL":"https:\/\/doi.org\/10.1016\/0002-9343(93)90056-u","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[1993,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: Risk factors and implications for dosing in patients with liver disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0002-9343(93)90056-U","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1993 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}